In vitro antileishmanial properties of neutron-irradiated meglumine antimoniate

Carregando...
Imagem de Miniatura

Data

Data de publicação

Orientador

Título da Revista

ISSN da Revista

Título do Volume

É parte de

É parte de

É parte de

Brazilian Archives of Biology and Technology
Exportar
Mendeley

Projetos de Pesquisa

Unidades Organizacionais

Fascículo

Resumo
Pentavalent antimony, as meglumine antimoniate (Glucantime) or sodium stibogluconate (Pentostam), is the main treatment for leishmaniasis, a complex of diseases caused by the protozoan Leishmania, and an endemic and neglected threat in Brazil. Despite over half a century of clinical use, their mechanism of action, toxicity and pharmacokinetic data remain unknown. The analytical methods for determination of antimony in biological systems remain complex and have low sensitivity. Radiotracer studies have a potential in pharmaceutical development. The aim of this study was to obtain a radiotracer for antimony, with suitable physical and biological properties. Meglumine antimoniate was neutron irradiated inside the IEA-R1 nuclear reactor, producing two radioisotopes 122Sb and 124Sb, with high radionuclidic purity and good specific activity. This compound showed the same antileishmanial activity as the native compound. The use of the radiotracers, easily created by neutron irradiation, could be an interesting tool to solve important questions in antimonial pharmacology.

Como referenciar
BORBOREMA, S.E.T.; ANDRADE JUNIOR, H.F.; OSSO JUNIOR, J.A.; NASCIMENTO, N. In vitro antileishmanial properties of neutron-irradiated meglumine antimoniate. Brazilian Archives of Biology and Technology, v. n.esp. 2, n. 48, p. 63-67, 2005. DOI: 10.1590/S1516-89132005000700009. Disponível em: http://repositorio.ipen.br/handle/123456789/5510. Acesso em: 30 Dec 2025.
Esta referência é gerada automaticamente de acordo com as normas do estilo IPEN/SP (ABNT NBR 6023) e recomenda-se uma verificação final e ajustes caso necessário.

Agência de fomento

Coleções